"Our single cell blastomere technology directly addresses the President's ethical concerns and, unlike the other potential solutions described in the order, is available today. We are encouraged by the NIH's willingness to explore ways to increase the federally approved stem cell lines available and hope they will consider our technique for federal funding," remarked William M. Caldwell IV, Chairman and CEO of Advanced Cell Technology. "We believe that such consideration reflects the will of the American people to bring novel therapies derived from stem cell research to patients with few or no alternatives."
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company operates facilities in California and Massachusetts.
For more information, visit http://www.advancedcell.com
Statements in this news release regarding future financial and
operating results, future growth in research and development programs,
potential applications of our technology, opportunities for the company and
any other statements about the future expectations, beliefs, goals, plans,
or prospects expressed by management constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Any statements that are not statements of historical fact (including
|SOURCE Advanced Cell Technology, Inc.|
Copyright©2007 PR Newswire.
All rights reserved